NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

陣列設備的全球市場

Array Instruments

出版商 Global Industry Analysts, Inc. 商品編碼 957480
出版日期 內容資訊 英文 182 Pages
商品交期: 最快1-2個工作天內
價格
陣列設備的全球市場 Array Instruments
出版日期: 2021年04月01日內容資訊: 英文 182 Pages
簡介

全球陣列設備的市場規模在2020年∼2027年的分析期間中預計將以4.1%的年複合成長率增長,從2020年的9億9,330萬美元到2027年達到13億美元。本報告所分析市場區隔之一的DNA微陣列部門在分析期間結束前預測將以3.8%的年率增長,達到6億8,490萬美元的規模。

本報告提供全球陣列設備市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

目錄

I. 簡介,調查手法,調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19的影響和即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:47公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10375

Abstract:

Global Array Instruments Market to Reach $1.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Array Instruments estimated at US$993.3 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. DNA Microarrays, one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$684.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Protein Microarrays segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $292.3 Million, While China is Forecast to Grow at 3.9% CAGR

The Array Instruments market in the U.S. is estimated at US$292.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$233.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Other Segments Segment to Record 3.7% CAGR

In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$174.2 Million in the year 2020 will reach a projected size of US$226 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$146.7 Million by the year 2027.

Select Competitors (Total 47 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC.
  • MilliporeSigma
  • Mingyuan Medicare Development Company Limited
  • Molecular Devices LLC
  • Novus Biologicals LLC
  • OriGene Technologies, Inc.
  • Orla Protein Technologies Ltd.
  • Oxford Gene Technology
  • Partek, Inc.
  • Pepscan
  • PerkinElmer, Inc.
  • Phalanx Biotech Group
  • ProteoGenix
  • Qiagen NV
  • RayBiotech, Inc.
  • Retrogenix Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Clinical Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 22: USA Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 46: Europe Current & Future Analysis for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 79: Rest of Europe Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Rest of Europe 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 82: Rest of Europe Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 85: Asia-Pacific Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Asia-Pacific 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 88: Asia-Pacific Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 91: Rest of World Current & Future Analysis for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World Historic Review for Array Instruments by Segment - DNA Microarrays, Protein Microarrays and Other Segments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of World 15-Year Perspective for Array Instruments by Segment - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Segments for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of World Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 47